FPT announced it received a SAP® APJ Award for Partner Excellence 2025 for Regional Strategic Services Partner. Awards were presented by SAP to the top-performing partners in the Asian Pacific Japan (APJ) region that have made outstanding contributions to driving digital transformation for businesses that use SAP solutions. Recipients – in partnership with SAP – help customers adopt innovation, gain results rapidly, grow sustainably, and run more simply with SAP solutions. This press release fe...
Novotech, a globally recognized full-service clinical research organization (CRO) and scientific advisory company that provides biotech and small- to mid-sized pharma companies an accelerated path to market, has been recognized as the Best Contract Research Organization in Australia at the Asia-Pacific Biopharma Excellence Awards (ABEA) 2025. Novotech, headquartered in Australia with a global presence across 30+ offices, is not only a global CRO but a leading CRO in the Asia-Pacific region. Th...
Neos has launched "IndieTech Games," a label dedicated to publishing high-quality indie games worldwide, including in Japan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250320035646/en/IndieTechGames Neos entered the game development and publishing business for Nintendo Switch in 2019, starting with the release of "Shin chan: Me and the Professor on Summer Vacation - The Endless Seven-Day Journey" in Japan in 2021. The title later...
Netforce announces the granting of a second patent in the United States, Patent number: US 12 222 193 B2, ensuring the protection of its innovative electric glove, "EstunGlove," until 2041. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250326381263/en/Laurent Mollinari, CEO Netforce This new recognition strengthens Netforce's intellectual property, which had already obtained a first patent in 2017. With now two WIPO patents granted...
Novotech, a globally recognized full-service clinical research organization (CRO) and scientific advisory company, has released its newest preclinical report exploring the evolving landscape of small interfering RNA (siRNA) therapeutics. This report provides insights for biotech and pharmaceutical companies leveraging RNA-based precision medicine to develop next-generation treatments for oncology, metabolic disorders, and rare genetic diseases. This press release features multimedia. View the f...